a 2ϩ -induced Ca 2ϩ release (CICR) from the sarcoplasmic reticulum (SR) is the cornerstone of cardiac excitation-contraction coupling and Ca 2ϩ signaling. 1,2 However, as an amplification mechanism exhibiting a high degree of positive feed-back, it has to be kept in check by inhibitory systems to prevent spontaneous oscillatory Ca 2ϩ releases which could possibly trigger cardiac arrhythmias. Local control theory provides us with an initial frame-work to understand how this could be accomplished. 3 sensitive on store emptying, 7 and more sensitive during refilling. 8 This backward signal may be communicated from the SR lumen to the RyRs after Ca 2ϩ binding to calsequestrin (CSQ) and by means of allosteric interactions also involving the two small SR proteins junctin and triadin. Thus, any elevation of the SR Ca 2ϩ concentration would inevitably affect both features of the local control system, the diffusional dissipation of the released Ca 2ϩ and the Ca 2ϩ sensitivity of the RyRs. Furthermore, most conditions leading to arrhythmias because of spontaneous SR Ca 2ϩ release are also associated with Ca 2ϩ overload (eg, intoxication with cardiac glycosides, ischemia/reperfusion injury). Therefore, it is difficult to separate the two mechanisms contributing to local control and to examine the two possibilities independently of each other in experiments.
However, there are a few notable exceptions, such as the recently discovered mutations in the RyR 9 (and CSQ 10 ) proteins, where gating changes could indeed occur separate from and independent of SR Ca 2ϩ overload. To understand the pathophysiological consequences of these mutations it is very important to ascertain that the changes of the RyR gating induced by the mutations are per se sufficient to trigger arrhythmias, or whether SR Ca 2ϩ overload is required as well. Interestingly, these patients typically develop arrhythmias (catecholaminergic polymorphic ventricular tachycardia [CPVT]) during physical exercise or stress, which may increase RyR open probability further via SR Ca 2ϩ loading or RyR phosphorylation. 9 Thus, from the clinical and experimental manifestations of these channelopathies and CSQ protein mutations described above we cannot conclude whether alterations of RyR gating alone are sufficient to trigger spontaneous Ca 2ϩ waves causing arrhythmias. In the current issue of Circulation Research, Venetucci et al 11 will not only increase CICR by law of mass action, but is also thought to further sensitize the RyRs by the allosteric interactions mentioned above.
Based on these observations one can also see the well established finding of a reduced SR content under conditions of congestive heart failure from a different perspective. Reduced SR content is generally assumed to cause impaired cardiac function and to occur because of reduced SERCA2a expression, possibly further accentuated by an enhanced SR Ca 2ϩ leak via hyperphosphorylated RyRs. 12 In the light of the present findings, the low SR Ca 2ϩ content might actually reflect a beneficial and adaptive change of Ca 2ϩ signaling, to reduce the risk for arrhythmias caused by sensitized RyRs. Thus, the therapeutic strategy to increase the SR Ca 2ϩ load in these patients with pharmacological tools or gene therapy approaches to stimulate the SERCA2a may bear a certain risk, particularly when the SR Ca 2ϩ load increases too much. 13 Specifically targeting the RyRs to reduce the SR Ca 2ϩ leak may represent a promising alternative which is unlikely to cause Ca 2ϩ overload by itself. 14 
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